North American Prodromal Synucleinopathy Consortium

Part of paid clinical trials in Sun City, Arizona.

Sponsor
Washington University School of Medicine
Study ID
NCT03623672
Status
Enrolling By Invitation

Conditions

  • Dementia With Lewy Bodies
  • Lewy Body Disease
  • Multiple System Atrophy
  • Parkinson Disease
  • REM Sleep Behavior Disorder
  • REM Sleep Parasomnias

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Key Dates

Start date
Aug 29, 2018
Status verified
Nov 2024
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Prodromal Synucleinopathy Rating Scale [ Time Frame: 2 years ]

Locations (9)

FacilityCityStateZIPSite coordinators
Banner Sun Health Research InstituteSun CityArizona85351-
University of California Los AngelesLos AngelesCalifornia90095-
Stanford UniversityRedwood CityCalifornia94063-
Emory UniversityAtlantaGeorgia30322-
Massachusetts General HospitalBostonMassachusetts02145-
University of MinnesotaMinneapolisMinnesota55455-
Mayo ClinicRochesterMinnesota55905-
Washington UniversitySt LouisMissouri63110-
Portland VA Medical CenterPortlandOregon97239-

Find similar trials in Sun City, AZ

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Banner Sun Health Research Institute· Sun City, AZUniversity of California Los Angeles· Los Angeles, CAStanford University· Redwood City, CAEmory University· Atlanta, GAMassachusetts General Hospital· Boston, MAUniversity of Minnesota· Minneapolis, MN

Related Studies